Interim NSABP Leaders Will Not Nominate Chairman, Citing Exec. Committee “Bias”
In Brief: FDA approves Three-Hour Taxol Infusion; Foti Elected President Of NCCR; Luce Retires
PCI Files Application For Research Base COP
Eight applications Received For NSABP chairman
Pitt Criticizes NCI Stance On Repayment For Fraud Trials
Broder, Herberman, Decline To Coauthor Reanalysis of Data
“I Can’t Permit Destruction of NSABP,” Fisher Writes
Herberman: Progress Made To Stabilize NSABP
Trending Stories
- Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives - Michael Caputo appointed to President’s Cancer Panel
The cancer survivor and political operative says his appointment signals Trump’s interest in cancer, survivorship - The Galleri MCD vote: What FDA asked its advisors to ignore
- From “default dead” to living the future of cancer care
As founding CEO of GitLab, I went “founder mode” on my osteosarcoma - FDA advisory committee votes in favor of Galleri approval, but calls for removal of “early” detection claims
Clinical benefit will not be considered for approval, FDA says - The Directors: Two Gulf Coast cancer center directors on why NCI designation matters—and why they want it
Lucio Miele and Raghu Kalluri: Science and technology have changed what an aspiring cancer center must accomplish
